menu

Annual Awards '15 - The Pharmaceutical Society of Japan -


previous recipients
Annual Awards '15 << Back

  1. The Pharmaceutical Society of Japan Award '15
    • Hiroyoshi Ariga (Faculty of Pharmaceutical Sciences Hokkaido University, Professor)
      Common mechanisms of onsets of cancer and neurodegenerative diseases
    • Junichi Kobayashi (Graduate School of Pharmaceutical Sciences Hokkaido University, Professor)
      Search for New Bioactive Marine Natural Products and Application to Drug Development
    • Kazuichi Hayakawa (Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Professor)
      A Study on Development of High-Performance Analytical Methods for Environmental Chemicals and their Application in view of Pharmaceutical Sciences
    • Norio Matsuki (Graduate School of Pharmaceutical Sciences, The University of Tokyo, Emeritus Professor)
      Integrative Understanding of Brain Function

  2. The Pharmaceutical Society of Japan Award for Divisional Scientific Contribution '15
    • Motoo Tori (Tokushima Bunri University, Faculty of Pharmaceutical Sciences, Professor)
      Phytochemical analysis of diversity of terpenoids in some Asteraceae Plants and aynthetic studies of terpenoids
    • Masayoshi Imagawa (Graduate School of Pharmaceutical Sciences, Nagoya City University, Professor)
      Studies on the molecular mechanisms of early stage of adipocyte differentiation and multi-functional roles of adipogenic factors isolated newly

  3. The Pharmaceutical Society of Japan Award for Divisional Scientific Promotion '15
    • Hiromichi Fujino (Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University, Associate Professor )
      The roles of prostanaid receptors on cancer malignancy signaling
    • Masayoshi Arai (Department of Natural Products Chemistry, Graduate School Pharmaceutical Sciences, Osaka University, Associate Professor)
      Exploring new drug targets through the identification of target molecules of bioactive natural products
    • Hidetoshi Tokuyama (Graduate School of Pharmaceutical Sciences, Tohoku University, Professor)
      Total Syntheses of Complex Alkaloids based on Development of Novel Construction of Nitrogen Heterocycles

  4. The Pharmaceutical Society of Japan Award for Young Scientists '15
    • Masashi Ueda (Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Associate Professor)
      Development of radiolabeled molecular imaging probes for in vivo analysis of biological function
    • Daisuke Urabe (Graduate School of Pharmaceutical Sciences, The University of Tokyo, Lecturer)
      Studies Toward Radical-Based Total Synthesis of Complex Natural Products
    • Ryuta Koyama (Graduate School of Pharmaceutical Sciences, The University of Tokyo, Assistant Professor)
      Experimental epilepsy research for the development of anti-epileptogenic drugs.
    • Youhei Sohma (Graduate School of Pharmaceutical Sciences, The University of Tokyo, ERATO Group Leader �iLecturer�j)
      Medicinal Chemistry Targeting Aggregation of Amyloid-β
    • Ryo Takita (RIKEN Center for Sustainable Resource Science, Deputy Team Leader)
      Reaction Development on π-and σ-Conjugated Bonds and Creation of Innovative Functions
    • Masanori Tachikawa �iGraduate School of pharmaceutical Sciences, Tokyo University, Associate Professor�j
      Spatial regulation of neuroactive substances tissue disposition based on localization and functional multiplicity of transporters
    • Shin-ya Morita (Shiga University of Medical Science, Associate Professor )
      Molecular mechanisms for disorders associated with abnormalities of membrane phospholipid metabolism
    • Hikaru Yanai (Tokyo University of Pharmacy and life Sciences, Associate Professor)
      Development of Novel Synthetic Reactions for Organofluorine Compounds and Their Applications
     
  5. The Pharmaceutical Society of Japan Award for Drug Research and Development '15
    • Reserch and Development of novel Anti-cancer drug mogamulizumab for adult T-cell Leukemia-lymphoma (Humanized anti-CCR4 antibody using high ADCC POTELLIGENT technology)
      Kenya Shitara (Director of Legal and Intellectual Property Development, Kyowa HakkoKirin CO.Ltd, Executive officer)
      Kazuyasu Nakamura (Tokyo Research Park, Research and Development Division, Kyowa HakkoKirin CO.Ltd, Deputy Direcutor)
      Koji Matsushima(Department of Molecular Preventive Medicine, Factry of Medicine, University of Tokyo, Professor)
      Shiro Akinaga (Research and Development Division Kyowa HakkoKirin CO.Ltd, Fellow)
      Ryuzo Ueda (Development of Tumor Immunology, School of Medicine, Aichi Medical University, Professor)
     
  6. The 38 th Sato Memorial Fund
    • Masatomo Miura (Department of Pharmacy, Akita University Hospital, Professor)
      Establishment of personalized therapy for tyrosine kinase inhibitors

<< Back